<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated">
      <PMID Version="1">32901394</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>05</Month>
        <Day>12</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>05</Month>
        <Day>12</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">0942-0940</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>163</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Acta neurochirurgica</Title>
          <ISOAbbreviation>Acta Neurochir (Wien)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Percutaneous image-guided biopsy in malignant peripheral nerve sheath tumors.</ArticleTitle>
        <Pagination>
          <StartPage>515</StartPage>
          <EndPage>519</EndPage>
          <MedlinePgn>515-519</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00701-020-04556-7</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND">The decision to biopsy a peripheral nerve tumor is largely based on its presumed behavior and prognosis, determined by patient history, clinical exam, and radiologic characteristics. Percutaneous image-guided biopsy is not without risk in patients with malignant peripheral nerve sheath tumors (MPNSTs); in particular, there may be concern regarding worsening neurologic function, increasing neuropathic pain, and incorrect or absent diagnosis.</AbstractText>
          <AbstractText Label="METHODS">Following approval by our institutional review board, we reviewed records from 1990 to 2019 at our institution's three main sites ("our institution"). Patients with pathology-proven MPNST were selected. Further inclusion criteria included image-guided percutaneous biopsy performed at our institution, pathology report available for review, and follow-up documentation to determine post-biopsy complications.</AbstractText>
          <AbstractText Label="RESULTS">Three hundred thirty-one patients with MPNST were reviewed. In total, 73 patients undergoing image-guided percutaneous biopsies were included. Twenty-two (30.1%) had biopsy-related complications. This included ten patients with misdiagnosis (13.7%) and six patients with non-diagnostic biopsies (8.2%). Six patients had new or worsened pain that resolved with time and neuropathic pain medication (8.2%), and one patient had subjectively worsened proximal weakness (1.3%) which resolved.</AbstractText>
          <AbstractText Label="CONCLUSION">We found nearly a third of patients undergoing biopsy had a biopsy-related complication. The single largest complication was the inability to obtain an accurate diagnosis (21.9%) with the first biopsy. This may lead to the need for repeat percutaneous or open biopsies, or a non-oncologic initial surgery with implications for disease-free and overall survival. Neurologic complications including exacerbation of pain or a deficit were rare and transient. It remains important that clinicians balance the potential risks and benefits based on individual patient characteristics when determining the necessity of an image-guided percutaneous biopsy.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Pendleton</LastName>
            <ForeName>Courtney</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Departments of Neurosurgery and Radiology, Mayo Clinic, 200 First Street SW, Gonda 8-214, Rochester, MN, 55905, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Howe</LastName>
            <ForeName>B Matthew</ForeName>
            <Initials>BM</Initials>
            <AffiliationInfo>
              <Affiliation>Departments of Neurosurgery and Radiology, Mayo Clinic, 200 First Street SW, Gonda 8-214, Rochester, MN, 55905, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Spinner</LastName>
            <ForeName>Robert J</ForeName>
            <Initials>RJ</Initials>
            <Identifier Source="ORCID">0000-0003-0443-7763</Identifier>
            <AffiliationInfo>
              <Affiliation>Departments of Neurosurgery and Radiology, Mayo Clinic, 200 First Street SW, Gonda 8-214, Rochester, MN, 55905, USA. spinner.robert@mayo.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>09</Month>
          <Day>08</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Austria</Country>
        <MedlineTA>Acta Neurochir (Wien)</MedlineTA>
        <NlmUniqueID>0151000</NlmUniqueID>
        <ISSNLinking>0001-6268</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003951" MajorTopicYN="Y">Diagnostic Errors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D061705" MajorTopicYN="N">Image-Guided Biopsy</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009437" MajorTopicYN="N">Neuralgia</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018319" MajorTopicYN="N">Neurofibrosarcoma</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Malignant peripheral nerve sheath tumor</Keyword>
        <Keyword MajorTopicYN="Y">Neurologic deficit</Keyword>
        <Keyword MajorTopicYN="Y">Percutaneous image-guided biopsy</Keyword>
        <Keyword MajorTopicYN="Y">Tissue diagnosis</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>6</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>8</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>9</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>5</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>9</Month>
          <Day>9</Day>
          <Hour>5</Hour>
          <Minute>31</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32901394</ArticleId>
        <ArticleId IdType="doi">10.1007/s00701-020-04556-7</ArticleId>
        <ArticleId IdType="pii">10.1007/s00701-020-04556-7</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Brahmi M, Thiesse P, Ranchere D, Mognetti T, Pinson S, Renard C, Decouvelaere AV, Blay JY, Combemale P (2015) Diagnostic accuracy of PET/CT-guided percutaneous biopsies for malignant peripheral nerve sheath tumors in neurofibromatosis type 1 patients. PLoS One 10:e0138386. https://doi.org/10.1371/journal.pone.0138386</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0138386</ArticleId>
            <ArticleId IdType="pubmed">26445379</ArticleId>
            <ArticleId IdType="pmc">4596851</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Graham DS, Russell TA, Eckardt MA, Motamedi K, Seeger LL, Singh AS, Bernthal NM, Kalbasi A, Dry SM, Nelson SD, Elashoff D, Levine BD, Eilber FC (2019) Oncologic accuracy of image-guided percutaneous core-needle biopsy of peripheral nerve sheath tumors at a high-volume sarcoma center. Am J Clin Oncol 42:739–743. https://doi.org/10.1097/COC.0000000000000591</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/COC.0000000000000591</ArticleId>
            <ArticleId IdType="pubmed">31436746</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Makise N, Sekimizu M, Kubo T, Wakai S, Hiraoka N, Komiyama M, Fukayama M, Kawai A, Ichikawa H, Yoshida A (2018) Clarifying the distinction between malignant peripheral nerve sheath tumor and dedifferentiated liposarcoma: a critical reappraisal of the diagnostic utility of MDM2 and H3K27me3 status. Am J Surg Pathol 42:656–664. https://doi.org/10.1097/PAS.0000000000001014</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/PAS.0000000000001014</ArticleId>
            <ArticleId IdType="pubmed">29309298</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mustapar N, Zawawi MSF, Tuan Sharif SE (2020) The value of H3K27me3 Immunohistochemistry in differentiating malignant peripheral nerve sheath tumour with its histologic mimickers. Asian Pac J Cancer Prev 21:699–705. https://doi.org/10.31557/APJCP.2020.21.3.699</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.31557/APJCP.2020.21.3.699</ArticleId>
            <ArticleId IdType="pubmed">32212796</ArticleId>
            <ArticleId IdType="pmc">7437312</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ogose A, Hotta T, Morita T, Higuchi T, Umezu H, Imaizumi S, Hatano H, Kawashima H, Gu W, Endo N (2004) Diagnosis of peripheral nerve sheath tumors around the pelvis. Jpn J Clin Oncol 34:405–413. https://doi.org/10.1093/jjco/hyh072</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jjco/hyh072</ArticleId>
            <ArticleId IdType="pubmed">15342668</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pendleton C, Spinner RJ (2020) Image-guided percutaneous biopsy of peripheral nerve tumors of indeterminate nature: risks and benefits. Acta Neurochir 162:1425–1429. https://doi.org/10.1007/s00701-020-04257-1</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00701-020-04257-1</ArticleId>
            <ArticleId IdType="pubmed">32040620</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perez-Roman RJ, Shelby Burks S, Debs L, Cajigas I, Levi AD (2020) The risk of peripheral nerve tumor biopsy in suspected benign etiologies. Neurosurgery 86:E326–E332. https://doi.org/10.1093/neuros/nyz549</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/neuros/nyz549</ArticleId>
            <ArticleId IdType="pubmed">31927583</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pianta M, Chock E, Schlicht S, McCombe D (2015) Accuracy and complications of CT-guided core needle biopsy of peripheral nerve sheath tumours. Skelet Radiol 44:1341–1349. https://doi.org/10.1007/s00256-015-2185-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00256-015-2185-6</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reuss DE, Habel A, Hagenlocher C, Mucha J, Ackermann U, Tessmer C, Meyer J, Capper D, Moldenhauer G, Mautner V, Frappart PO, Schittenhelm J, Hartmann C, Hagel C, Katenkamp K, Petersen I, Mechtersheimer G, von Deimling A (2014) Neurofibromin specific antibody differentiates malignant peripheral nerve sheath tumors (MPNST) from other spindle cell neoplasms. Acta Neuropathol 127:565–572. https://doi.org/10.1007/s00401-014-1246-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00401-014-1246-6</ArticleId>
            <ArticleId IdType="pubmed">24464231</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tottrup M, Eriksen JD, Hellfritzsch MB, Sorensen FB, Baad-Hansen T (2020) Diagnostic accuracy of ultrasound-guided core biopsy of peripheral nerve sheath tumors. J Clin Ultrasound 48:134–138. https://doi.org/10.1002/jcu.22769</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jcu.22769</ArticleId>
            <ArticleId IdType="pubmed">31441068</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
